Tilray Medical Strengthens German Market Presence with Introduction of New Good Supply Cannabis Offerings
LONDON and NEUMÜNSTER, Germany – August 28, 2025 – Tilray Medical, a division of Tilray Brands, Inc., a global leader in medicinal cannabis, today announced a significant expansion of its offerings in Germany with the introduction of three new EU-GMP certified medical cannabis strains under its popular Good Supply brand. This strategic move aims to broaden access to high-quality medical cannabis options for patients and physicians across Europe’s largest medical cannabis market.
New Strains and Rollout Schedule
The newly launched medical cannabis products are Good Supply Cannabisblüten THC 22 IIM, Good Supply Cannabisblüten THC 25 MMK, and Good Supply Cannabisblüten THC 18 LLD. Each of these strains has undergone rigorous EU-GMP certification, ensuring adherence to the highest quality and safety standards required for medicinal products in Germany.
These premium cannabis flower products will be available in two formats: 15-gram jars specifically for patients, and larger 500-gram packs intended for pharmacies. The rollout will commence sequentially throughout September and early October 2025. Good Supply Cannabisblüten THC 22 IIM is slated for availability at the beginning of September, followed by Good Supply Cannabisblüten THC 25 MMK on September 19. The third strain, Good Supply Cannabisblüten THC 18 LLD, is expected to be available by the end of September or early October.
The Good Supply Brand: Quality and Innovation in Focus
The introduction of these new cannabis products under the Good Supply brand signifies Tilray Medical’s commitment to leveraging its established portfolio for the German market. Good Supply is recognized in Canada as a leading cannabis brand, known for its consistent quality and affordability, offering a range of cultivars to meet diverse patient needs. This expansion marks an adaptation of that successful Canadian brand, tailoring its innovations to comply with and serve the specific requirements of German medical cannabis patients and healthcare practitioners.
“By introducing these new Good Supply strains to the German market, we are not only expanding access to premium, EU-GMP certified options for physicians and patients, but also reaffirming our role as a trusted partner in medical cannabis across continents,” said Rajnish Ohri, Managing Director, International, Tilray Brands. “Our robust international platform and strong distribution network empower us to deliver consistent quality and reliable supply—ensuring that those in need have access to safe, effective medical choices.”
Tilray’s Established German Presence
Tilray Medical has a deep-rooted history and significant presence in Germany, having been among the first to establish GMP-certified cannabis production facilities in Europe, including in Germany itself. The company operates a sophisticated logistics and distribution network across the country, ensuring that its EU-GMP certified medical cannabis products are reliably supplied to pharmacies for prescription dispensing.
This expansion builds upon Tilray’s previous efforts to diversify its German medical cannabis portfolio, which has included the introduction of various medical cannabis extracts and other flower-based products. Tilray’s commitment extends to fostering an environment of trust and education, empowering the therapeutic alliance between patients and healthcare practitioners.
Impact on the German Medical Cannabis Landscape
The German medical cannabis market is Europe’s largest, and Tilray’s continued investment and product launches underscore its strategic importance. By providing additional high-THC options and maintaining stringent quality control through EU-GMP certification, Tilray Medical aims to meet the growing demand from physicians seeking effective treatment options for their patients across a range of conditions. These new launches are expected to further solidify Tilray’s position as a leading supplier and a key contributor to the advancement of medical cannabis care in Germany.
Tilray’s ongoing efforts to expand its product lines reflect a broader commitment to patient care and the company’s dedication to transforming lives through safe and reliable access to medical cannabis solutions. The introduction of these Good Supply strains represents another step in Tilray Medical’s mission to meet the evolving needs of the German healthcare sector.
